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carefully designed statistical modeling that appropriately
adjusts for measured time-dependent confounding might
provide answers for policy-makers and others.
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To the Editor: We read with interest the article by Zaidi
et al.1 They reported a 17-year-old boy with multiple
vasculitic involvement of the heart, liver, pancreas, kidneys,
and skin, and the authors suggested that these findings might
be secondary to Henoch–Scho¨nlein purpura (HSP). In this
situation, however, we should think about the possibility of
polyangiitis overlap syndrome before concluding that HSP
itself caused multiorgan involvement in this case. As this
overlap has often been diagnosed by postmortem autopsy,
the incidence of polyangiitis overlap syndrome in patients
with HSP is unknown.
Recently, Watanabe et al.2 reported a fatal case of systemic
vasculitis combined with HSP and polyarteritis nodosa in a
56-year-old man. He complained of arthralgia, purpura of
both lower extremities, nasal bleeding, and tarry stool, and
acute renal failure was noted at the time of admission to
hospital. A skin biopsy from the purpura lesion exhibited
leucocytoclastic vasculitis with IgA deposition, and HSP
was considered. However, renal failure progressed rapidly
and subsequently was complicated by acute myocardial
infarction. Postmortem examination revealed polyarteritis
nodosa-type necrotizing vasculitis in the kidneys, heart, and
mesentery resulting in acute multiple infarctions of these
organs, suggesting a polyangitis overlap syndrome.
After reviewing the cases of autopsy, Pacheco et al.3
reported that the reason why systemic necrotizing vasculitis
had been underdiagnosed in the past might partly be due to
the lack of specificity of the most common symptoms and
the paucity of characteristic clinical and organ-specific
manifestations that lead to confusion with more prevalent
conditions.
Therefore, when a patient presents with atypical presenta-
tion of HSP, polyangiitis overlap syndrome should also be
suspected, considering its fatal outcome in contrast to a
benign nature of HSP.
1. Zaidi M, Singh N, Kamran M et al. Acute onset of hematuria and
proteinuria associated with multiorgan involvement of the heart, liver,
pancreas, kidneys, and skin in a patient with Henoch-Scho¨nlein purpura.
Kidney Int 2008; 73: 503–508.
2. Watanabe K, Abe H, Mishima T et al. Polyangitis overlap syndrome: a fatal
case combined with adult Henoch-Scho¨nlein purpura and polyarteritis
nodosa. Pathol Int 2003; 53: 569–573.
3. Pacheco Cuadros R, Sendino Revuelta A, Morales Bastos C et al. Systemic
necrotizing vasculitis in autopsy. Rev Clin Esp 2001; 201: 378–384.
Jae I. Shin1 and Jae S. Lee1
1Department of Pediatrics, The Institute of Kidney Disease, Yonsei University
College of Medicine, Severance Children’s Hospital, Seoul, Korea
Correspondence: Jae S. Lee, Department of Pediatrics, Yonsei University
College of Medicine, Sungsan-Ro 250, Seodaemun-Ku, C.P.O. Box 8044,





Kidney International (2008) 74, 828–829; doi:10.1038/ki.2008.278
We thank the authors Dr Jae Shin and Jae Seung Lee1 for
their thoughtful comments. They raise the possibility that
the 17-year-old boy with multiple organ involvement and
IgA deposition on kidney biopsy could have polyangiitis
overlap syndrome (POS). They refer to the report of such
a case by Watanabe et al.2 POS is a term proposed for
cases associated with overlapping features of several forms
of vasculitis, including Henoch-Scho¨nlein purpura (HSP),
Wegener’s granulomatosus, Churg–Strauss syndrome,
microscopic polyangitis (MPA), and polyarteritis nodosa
(PN).2,3 We agree with the authors that the clinical
symptoms in our patient are not very specific to HSP.
POS however, is unlikely for the following reasons. (1) The
renal and skin biopsy findings: Kidney involvement in PN
is characterized by inflammation and fibrinoid necrosis
of renal arteries with sparing of glomeruli. Therefore,
the presence of glomerulonephritis and the absence of
necrotizing arteritis or renal infarction in our patient
argue against PN. (2) In contrast, MPA and HSP are small
vessel vasculitides commonly associated with glomerulo-
nephritis. Pauci-immune necrotizing and crescentic
glomerulonephritis, characterized by glomerular necrosis
without endocapillary hypercellularity on light microscopy
along with the absence or paucity of immune deposits
on immunofluorescence and electron microscopy, is the
typical form of glomerulonephritis in patients with MPA.
In our patient, the presence of endocapillary hyper-
cellularity on light microscopy, strong IgA deposition
in glomeruli and dermal vessels on immunofluorescence,
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and abundant electron-dense mesangial deposits ultra-
structurally are consistent with HSP and not MPA. The
anti-neutrophil cytoplasm antibodies seronegativity is
an additional factor against MPA. (3) MPA and PN are
aggressive conditions that without treatment are associated
with high mortality and morbidity rates. Our patient was
treated with steroids (pulse methylprednisolone for 3 days
followed by oral prednisone) and angiotensin converting
enzyme inhibitor. He showed a significant decrease in
proteinuria and maintained normal renal function on
follow-up at 2 months, which would be unexpected if he
had MPA or PN. Thus, based on the clinical and pathologic
findings, we believe that the patient has HSP with multi-
organ involvement and not POS.
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The use of online clearances in
dialysis
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To the Editor: Real-time measurement of dialysis efficacy is
sought by all practicing renal physicians in charge of dialysis
patients. Thus, we were very interested in the article by Gross
et al.,1 entitled ‘Online clearance measurement in high-
efficiency hemodiafiltration’. We were surprised to discover
that the paper reported the use of ionic dialysance to estimate
urea clearance, as we consider this method to be widely
accepted and that it was made commercially available quite a
long time ago.
Ionic dialysance as commented by Gross et al. was first
proposed to estimate urea clearance by Polaschegg2 and
Petitclerc et al.3 in 1993. Given the simplicity of the method,
many investigators have adopted it. We used ionic dialysance
for evaluating the efficacy of different types of online
hemodiafiltration after validating the results with blood
measurements of urea clearances in vivo and reported it in
the late nineties.4
Based on the accuracy of ionic dialysance in estimating
urea clearance, we further used this method to evaluate the
expected modifications in clearances by varying the convection
flows in pre- and post-dilutional high-efficiency hemodiafil-
tration. Our studies allowed us to define a simplified formula
to predict the clearance changes linked to convection. We
tested these formulas in vivo in dialysis patients and we
proposed their use in clinics. These studies were reported in
the journal in 2000.5
Although we do not know the reasons that led the authors
to overlook our reports when stating ‘a direct comparison of
ionic dialysance with blood-side clearance has been made
only in standard hemodialysis,’ we were disappointed to
discover that no new findings were presented in the current
paper. We would have been interested to know whether
the results of Gross et al. fit with the formulas we proposed in
our Technical Note of 2000 in Kidney International.5 This
would have represented a step forward in using ionic
dialysance in estimating the efficacy of high-efficiency
hemodiafiltration. Unfortunately, the current paper reports
a high rate of discarded measurements due to ‘technical
problems’ (48 out of 108 online measurements had to be
excluded for this reason), and adds little to the existing
literature.
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We have read with interest the letter submitted by Argile´s
et al.1 concerning our article on online clearance measure-
ment in high-efficiency hemodiafiltration.
Ionic dialysance measurement is a surrogate method to
evaluate urea clearance that has been extensively validated
in mainly diffusive hemodialysis. To perform in vivo
measurements of ionic dialysance, a transient conductivity
change of the dialysate is automatically applied and
dialysance is calculated from the time courses of the
conductivities at the dialysate inlet and outlet. In high-
efficiency hemodiafiltration, convection becomes the
predominant part of the cleansing process.
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